About: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Sector: Healthcare
Industry: Medical Devices
Latest price: $152.50 (+2.40%)
PODD NASDAQ Insulet Corporation
Insulet Corporation share price
Atividade de preço de PODD
Último preço
$ 152,500
Variação (24h)
3,57 USD (2,40%)
Volume
1.29M
Volume (média 4 sem.)
-
Abertura
$ 150,54
Variação do dia
$ 150,54 - $ 152,66
Fechamento anterior
$ 148,93
Último negócio
29 Oct, 8:02 pm GMT+0
Atrasado
29 Oct, 8:02 pm GMT+0
PODD price performance
Atrasado
29 Oct, 8:02 pm GMT+0
quote.marketSignals